Kang Liu

Kang Liu

Auto-generated profile, based on publicly available information

Kang Liu

Department of Osteology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2019 in Orthopaedic Surgery
Verified
Journal Article
Open access
PDF file
ZLZhong Liu
Zhong Liu
CLChun‐Wen Li
Chun‐Wen Li
YMYi‐Fan Mao
Yi‐Fan Mao
KLKang Liu
Kang Liu
BLBo‐Cheng Liang
Bo‐Cheng Liang
XSXiaolin Shi
Xiaolin Shi
Objective: To observe the effect of zoledronic acid on the reduction of acute bone loss and fracture rate in elderly postoperative patients with intertrochanteric fracture.Methods: From August 2012 to January 2015, a total of 482 patients with senile osteoporotic femoral intertrochanteric fracture, who accepted proximal femoral intramedullary fixation under anesthesia were analysed. The patients were divided into two groups. Treatment group (353 cases) were treated with 100 mL/5 mg of zoledronic acid injection in 1 week after operation, as well as orally taken 600 mg/d of calcium carbonate and active vitamin D3 400 IU/d. Control group (129 cases) were given the same dose of calcium carbonate and active vitamin D3 orally. Efficacy evaluation were conducted during different periods of medicationResults: Compared with pre‐medication, indexes of bone metabolism (TARP‐5b, CTX) in the treatment group were brought down, especially significantly statistically different after 12 months of medication. The treatment group performed superior to control group in alleviating the pain of back and posture changing (P < 0.05), improving bone density (P < 0.05), depressing re‐fracture rate (P < 0.01) after 24 months of medication. In addition, BP, PF and MH dimension scores were demonstrated with statistical significance (P < 0.05).Conclusions: The application of zoledronic acidin elderly postoperative patients with intertrochanteric fracture can not only relieve acute bone loss, reduce the incidence rate of re‐fracture, alleviate osteoporosis pain and the pain from osteoporotic fracture, but also improve bone metabolism and quality of life, which may offer an acceptable clinical opinion

25 November 2019 in Orthopaedic Surgery
Verified
Journal Article
Open access
PDF file
YYYi‐Ran Yang
Yi‐Ran Yang
CLChun‐Wen Li
Chun‐Wen Li
JWJun‐Hua Wang
Jun‐Hua Wang
XHXiao‐Sheng Huang
Xiao‐Sheng Huang
YYYi‐Feng Yuan
Yi‐Feng Yuan
XSXiaolin Shi
Xiaolin Shi
Objectives: To determine the mechanisms of ubiquitination in postmenopausal osteoporosis and investigate the ubiquitinated spectrum of novel targets between healthy postmenopausal women and postmenopausal osteoporosis patients, we performed ubiquitylome analysis of the whole blood of postmenopausal women and postmenopausal osteoporosis patients.Methods: To obtain a more comprehensive understanding of the postmenopausal osteoporosis mechanism, we performed a quantitative assessment of the ubiquitylome in whole blood from seven healthy postmenopausal women and seven postmenopausal osteoporosis patients using high‐performance liquid chromatography fractionation, affinity enrichment, and liquid chromatography coupled to tandem mass spectrometry (LC‐MS/MS). To examine the ubiquitylome data, we performed enrichment analysis using an ubiquitylated amino acid motif, Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway.Results: Altogether, 133 ubiquitinated sites and 102 proteins were quantified. A difference of more than 1.2 times is considered significant upregulation and less than 0.83 significant downregulation; 32 ubiquitinated sites on 25 proteins were upregulated and 101 ubiquitinated sites on 77 proteins were downregulated. These quantified proteins, both with differently ubiquitinated sites, participated in various cellular processes, such as cellular processes, biological regulation processes, response to stimulus processes, single‐organism and metabolic processes. Ubiquitin conjugating enzyme activity and ubiquitin‐like protein conjugating enzyme activity were the most highly enriched in molecular function of upregulated sites with corresponding proteins, but they were not enriched in downregulated in sites with corresponding proteins. The KEGG pathways analysis of quantified proteins with differentiated ubiquitinated sites found 13 kinds of molecular interactions and functional pathways, such as glyoxylate and decarboxylate metabolism, dopaminergic synapse, ubiquitin‐mediated proteolysis, salivary secretion, coagulation and complement cascades, Parkinson's disease, and hippo signaling pathway. In addition, hsa04120 ubiquitin‐mediated proteolysis was the most highly enriched in proteins with upregulated sites, hsa04610 complement and coagulation cascades was the most highly enriched in proteins with downregulated ubiquitinated sites, and hsa04114 Oocyte meiosis was the most highly enriched among all differential proteins.Conclusion: Our study expands the understanding of the spectrum of novel targets that are differentially ubiquitinated in whole blood from healthy postmenopausal women and postmenopausal osteoporosis patients. The findings will contribute toward our understanding of the underlying proteostasis pathways in postmenopausal osteoporosis and the potential identification of diagnostic biomarkers in whole blood.

29 October 2019 in Orthopaedic Surgery
Verified
Journal Article
Open access
PDF file
LZLi‐Li Zhang
Li‐Li Zhang
CLChun‐Wen Li
Chun‐Wen Li
KLKang Liu
Kang Liu
ZLZhong Liu
Zhong Liu
BLBo‐Cheng Liang
Bo‐Cheng Liang
XSXiaolin Shi
Xiaolin Shi
Objective: For the purpose of providing evidence for the treatment of osteoporosis and osteopenia, this study retrospectively identified succinylation‐modified sites and proteins in postmenopausal women, and bioinformatics analysis were performed.Methods: From January 2016 to June 2018, a total of 30 postmenopausal women aged from 55 to 70 years old were assigned to three groups: 10 cases with osteoporosis; 10 cases with osteopenia; and 10 cases with normal bone mass. Subsequently, the serum samples were collected from all cases for succinyl‐proteome. Measures comprised label‐free quantitative analysis, succinylation enrichment techniques, the liquid chromatograph–mass spectrometer/mass spectrometer (LC‐MS/MS) methods, and bioinformatics.Results: A total of 113 succinylation sites on 35 proteins were identified based on quantitative information. The variation of the different multiple folds were more than 1.2 times as a significant increase for up‐regulated and less than 1/1.2 times as a significant decrease for down‐regulated. Among the quantified succinylation sites, 66 were up‐regulated and 11 down‐regulated in the Osteopenia/Normal comparison group, 24 were up‐regulated and 44 down‐regulated in the Osteoporosis/Osteopenia comparison group, 45 were up‐regulated and 32 down‐regulated in the Osteoporosis/Normal comparison group. Among the quantified succinylation proteins, 24 were up‐regulated and 7 down‐regulated in the Osteopenia/Normal comparison group, 15 were up‐regulated and 20 down‐regulated in the Osteoporosis/Osteopenia comparison group, 20 were up‐regulated and 17 down‐regulated in the Osteoporosis/Normal comparison group. The percentage of proteins differed in immune response, signaling pathway, proteolysis, lymphocyte, leukocyte, and cell activation. Four differentially expressed proteins (apolipoprotein A‐I, apolipoprotein A‐II, hemoglobin subunit alpha, and haptoglobin) contained quantitative information; they were mediated with receptors, factors, mechanisms, that related to bone metabolism. Hemoglobin subunit alpha was screened for diagnosis of osteopenia.Conclusions: The succinyl‐proteome experimental data indicated that apolipoprotein A‐I, apolipoprotein A‐II, hemoglobin subunit alpha, and haptoglobin were valuable for diagnosis and treatment in postmenopausal women with osteoporosis and osteopenia.

1 December 2022 in Journal of Biophotonics
Verified
Journal Article
Closed access
YBYupei Bian
Yupei Bian
YLYang Li
Yang Li
KLKang Liu
Kang Liu
HHHoushu He
Houshu He
YFYingmei Feng
Yingmei Feng
Xia YuXia Yu
Xia Yu

27 June 2024 in Advanced Biology
Verified
Journal Article
Closed access
SMShilong Meng
Shilong Meng
XZXu Zhang
Xu Zhang
YYYang Yu
Yang Yu
MTMinghao Tong
Minghao Tong
YYYifeng Yuan
Yifeng Yuan
KLKang Liu
Kang Liu

7 August 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
YXYawei Xu
Yawei Xu
CWChengjie Wang
Chengjie Wang
KLKang Liu
Kang Liu
SPSee Pdf
See Pdf
Background: Periprosthetic joint infection (PJI) is among the most serious complications following total joint replacement. Biomarkers hold crucial importance in PJI diagnosis. However, their relative diagnostic accuracy has not yet been systematically compared across various established markers. This study comprehensively evaluated the diagnostic accuracy of established serum and synovial fluid biomarkers for PJI through a network meta-analysis (NMA).Methods: A systematic search was conducted in PubMed, Web of Science, Embase, and Cochrane Library from the inception of each database to January 1, 2026. Search terms included “periprosthe*”, “prosthe*”, and terms related to diagnostic accuracy. Two reviewers independently screened the literature, extracted data, and appraised study quality using the QUADAS-2 tool. A NMA based on an ANOVA model was performed using R software (version 4.5.1). The primary outcome measures covered diagnostic odds ratio (DOR), sensitivity, specificity, superiority index (SI), and the surface under the cumulative ranking curve (SUCRA).Result: We ultimately included 335 studies; 321 of these were eligible for a NMA, covering 164,812 participants (of whom 34,301 were diagnosed with PJI). Among serum biomarkers, C-reactive protein (CRP) to albumin ratio (CAR) had the highest DOR (DOR: 30.33, 95% CrI: 18.32–46.05), followed by CRP/albumin-to-globulin ratio (CAGR) (19.84, 8.98–36.54) and CRP (14.05, 12.87–15.30). Overall, the diagnostic efficacy of synovial fluid biomarkers was notably superior to that of serum biomarkers, with Calprotectin (CLP) exhibiting the highest DOR (110.86, 58.36–186.30), followed by neutrophil gelatinase-associated lipocalin (NGAL) (100.28, 27.03–244.29) and alpha-defensin (AD) (73.81, 55.92–95.03). AD (SI: 18.80, 95% CrI: 5.67–27.00), CLP (18.41, 4.33–29.00), and absolute neutrophil count (ANC) (13.14, 1.80–27.00) had greater diagnostic advantage than traditional white blood cell count (WBC) (1.93, 0.64–4.20) and polymorphonuclear neutrophil percentage (PMN%) (1.46, 0.47–3.00). The ranking trend of sensitivity and relative sensitivity aligned with that of DOR and SI. Subgroup analyses revealed that synovial fluid biomarkers performed better in knee PJI than in hip PJI; acute infections predominantly showed elevated ANC and WBC levels, whereas chronic infections predominantly showed elevated CLP and AD levels.Conclusion: Synovial fluid biomarkers (particularly CLP, NGAL, and AD) markedly outperform serum biomarkers in PJI diagnosis, with CAR as the optimal serum biomarker. These findings furnish evidence-based support for tiered selection and integrated testing strategies for clinical biomarkers.